Authors
Loading...
Analysis shows high gyrB prevalence and mutations linked to carbapenem resistance in clinical isolates, suggesting urgent molecular surveillance.
Fayad et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: